Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
GoGreen Membership

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Published Online October 25, 2007
Science DOI: 10.1126/science.1146157

Reports

Submitted on June 6, 2007
Accepted on October 15, 2007

Hold Your Horses: Impulsivity, Deep Brain Stimulation, and Medication in Parkinsonism

Michael J. Frank 1*, Johan Samanta 2, Ahmed A. Moustafa 1, Scott J. Sherman 3

1 Department of Psychology and Program in Neuroscience, University of Arizona, Tucson, AZ 85721, USA.
2 Banner Good Samaritan Medical Center, Phoenix, AZ, USA. ; Department of Neurology, University of Arizona, Tucson, AZ, USA.
3 Department of Neurology, University of Arizona, Tucson, AZ, USA.

* To whom correspondence should be addressed.
Michael J. Frank , E-mail: mfrank{at}u.arizona.edu

Deep brain stimulation (DBS) of the subthalamic nucleus dramatically improves the motor symptoms of Parkinson’s disease, but causes cognitive side effects such as impulsivity. Here we show that DBS selectively interferes with the normal ability to slow down when faced with decision conflict. While on DBS, patients actually sped up under high conflict conditions. This form of impulsivity was not affected by dopaminergic medication status. Instead, medication impaired patients’ ability to learn from negative decision outcomes. These findings implicate independent mechanisms leading to impulsivity in treated Parkinson’s patients, and were predicted by a single neurocomputational model of the basal ganglia.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Schizophrenia: A Computational Reinforcement Learning Perspective.
M. J. Frank (2008)
Schizophr Bull 34, 1008-1011
   Full Text »    PDF »
Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's disease.
T Soulas, J-M Gurruchaga, S Palfi, P Cesaro, J-P Nguyen, and G Fenelon (2008)
J. Neurol. Neurosurg. Psychiatry 79, 952-954
   Abstract »    Full Text »    PDF »
Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition.
J. B. Rowe, L. Hughes, B. C. P. Ghosh, D. Eckstein, C. H. Williams-Gray, S. Fallon, R. A. Barker, and A. M. Owen (2008)
Brain 131, 2094-2105
   Abstract »    Full Text »    PDF »
Comment on "Genetically Determined Differences in Learning from Errors".
M. Lucht and D. Rosskopf (2008)
Science 321, 200a
   Abstract »    Full Text »    PDF »
Role for Subthalamic Nucleus Neurons in Switching from Automatic to Controlled Eye Movement.
M. Isoda and O. Hikosaka (2008)
J. Neurosci. 28, 7209-7218
   Abstract »    Full Text »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)